Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic

2 years ago

EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT…

Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA

2 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / January 3, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to…

Greenfield Twin Born at Midnight at Natividad is Monterey County’s First Birth of 2022

2 years ago

Big Brother Born 15 Minutes Earlier in 2021 Twin Born at Midnight at Natividad is Monterey County’s First Birth of…

What Is Machine Learning and How Is It Beneficial for Healthcare Practices?

2 years ago

The goals of most healthcare technologies are simple: to improve patient outcomes while streamlining the treatment process for healthcare providers…

CardioComm Solutions Enters Loan Agreement

2 years ago

Toronto, Ontario--(Newsfile Corp. - December 31, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical…

West Island Brands Issues Options

2 years ago

Toronto, Ontario--(Newsfile Corp. - December 31, 2021) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"…

Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application

2 years ago

ORLANDO, FL / ACCESSWIRE / December 31, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the Korean Intellectual Property Office…

Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement

2 years ago

–  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – – Together…

Nuvectis Pharma Initiates Phase 1 Clinical Trial of NXP800

2 years ago

The Phase 1 Study Will be Comprised of Two Parts: Phase 1a Dose-escalation that will Evaluate the Safety and Tolerability…

Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles

2 years ago

DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable…